期刊
TRANSLATIONAL RESEARCH
卷 220, 期 -, 页码 153-166出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.trsl.2020.03.010
关键词
-
资金
- National Health and Medical Research Council [APP1140617]
- National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R33AI121627]
Wound infections associated with multidrug-resistant (MDR) bacteria are one of the important threats to public health. Bacteriophage (phage) therapy is a promising alternative or supplementary therapeutic approach to conventional antibiotics for combating MDR bacterial infections. In recent years, significant effort has been put into the development of phage formulations and delivery methods for topical applications, along with preclinical and clinical uses of phages for the treatment of acute and chronic wound infections. This paper reviews the application of phages for wound infections, with focus on the current status of phage formulations (including liquid, semi-solid and liposome-encapsulated formulations, phage-immobilized wound dressings), safety and efficacy assessment in clinical settings and major challenges to overcome.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据